Get started
Author

Gerlinde Mitterbauer‐Hohendanner

Observed names: G Mitterbauer-Hohendanner, G. Mitterbauer-Hohendanner, G. Mitterbauer‐Hohendanner, Gerlinde Mitterbauer-Hohendanner, Gertinde Mitterbauer-Hohendanner, Mitterbauer-Hohendanner, G, Mitterbauer-Hohendanner, Gerlinde
OpenAlex ID: A5074878867
Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML
2011 · Karl J. Aichberger, Susanne Herndlhofer, et al. · American Journal of Hematology · 297
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
2020 · Andreas Agathangelidis, Anastasia Chatzidimitriou, et al. · Blood · 133
PDF
Digital PCR: A Sensitive and Precise Method for KIT D816V Quantification in Mastocytosis
2017 · Georg Greiner, Michael Gurbisz, et al. · Clinical Chemistry · 83
A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR
2014 · H White, L Deprez, et al. · Leukemia · 79
PDF
KIT-D816V–independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib
2011 · Karoline V. Gleixner, Matthias Mayerhofer, et al. · Blood · 74
CD34+/CD38- stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin
2011 · H. Herrmann, S. Cerny-Reiterer, et al. · Haematologica · 67
PDF
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale
2016 · N C P Cross, H E White, et al. · Leukemia · 61
PDF
Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily
2010 · M.-T. Krauth, S. Herndlhofer, et al. · Haematologica · 60
PDF
Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL)
2004 · G Mitterbauer-Hohendanner, C Mannhalter, et al. · Leukemia · 40
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
2022 · Helen E. White, Matthew Salmon, et al. · Leukemia · 39
The biological and clinical significance of MLL abnormalities in haematological malignancies
2004 · G. Mitterbauer‐Hohendanner, C. Mannhalter · European Journal of Clinical Investigation · 33
Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma
2014 · J. Gebhart, K. Lechner, et al. · Thrombosis Research · 25
Cold antibody autoimmune hemolytic anemia and lymphoproliferative disorders: a retrospective study of 20 patients including clinical, hematological, and molecular findings
2014 · Cathrin Arthold, Cathrin Skrabs, et al. · Wiener klinische Wochenschrift · 24
Idiopathic bone marrow dysplasia of unknown significance (IDUS): definition, pathogenesis, follow up, and prognosis.
2011 · Peter Valent, Eva Jäger, et al. · PubMed · 23
Stability of Conversion Factors for BCR-ABL Monitoring -– Implications for the Frequency of Validation Rounds
2010 · Martin C. Müller, Umang Munjal, et al. · Blood · 8
N‐terminal pro‐brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia
2023 · Irene Graf, Georg Greiner, et al. · American Journal of Hematology · 7
PDF
Stable non-transforming minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia after autologous transplantation: origin from neoplastic yet ‘pre-leukemic’ stem cells?
2011 · Alexandra Böhm, Harald Herrmann, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
Molecular Disease Eradication is a Prerequisite for Long-term Remission in Patients with t(8;21) Positive Acute Myeloid Leukemia: a Single Center Study
2004 · Margit Mitterbauer, Gerlinde Mitterbauer-Hohendanner, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 5
Umbilical Cord Blood Transplantation Is a Feasible Rescue Therapeutic Option for Patients Suffering from Graft Failure after Previous Hematopoietic Stem Cell Transplantation
2016 · Marija Bojic, Nina Worel, et al. · Oncology · 4
The Leukemic Stem Cell (LSC) in Ph+ CML Is a CD34+/CD38−/Lin− Cell That Co-Expresses Dipeptidylpeptidase IV (CD26) and Disrupts LSC-Niche Interactions by Degrading the CXCR4 Ligand SDF-1α
2011 · Harald Herrmann, Irina Sadovnik, et al. · Blood · 3
Harmonized Testing for BCR-ABL Kinase Domain Mutations In CML: Results of a Survey and First Control Round within 28 National Reference Laboratories In Europe
2010 · Thomas Ernst, Feng Lin, et al. · Blood · 3
Comparison of BCR-ABL1 quantification in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemia
2020 · Georg Greiner, Franz Ratzinger, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2
Non‐Invasive Stratification of Portal Hypertension in Patients With BCR :: ABL1 ‐Negative Myeloproliferative Neoplasms
2025 · Lorenz Balcar, Lina Degenfeld‐Schonburg, et al. · Liver International · 1
PDF
NT-Probnp As Personalized Medicine Tool and New Biomarker Predicting Response to Chemotherapy and Survival in AML
2021 · Irene Graf, Georg Greiner, et al. · Blood · 1
Digital Droplet PCR: Next Generation KIT D816V Testing As Advanced Tool for Diagnosis and Prognostication in Mastocytosis
2017 · Georg Greiner, Michael Gurbisz, et al. · Blood · 1
Works count: 36
Citation count: 1,082
H-index: 14
I10-index: 14
Year
Topic
Type